|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Genomic_Health
gptkb:Thrive_Earlier_Detection
gptkb:Ashion_Analytics
gptkb:Base_Genomics
gptkb:Biomatrica
gptkb:Paradigm_Diagnostics
gptkb:Sampleminded
gptkb:Viomics
|
|
gptkbp:CEO
|
gptkb:Kevin_Conroy
|
|
gptkbp:collaboratedWith
|
gptkb:Mayo_Clinic
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusesOn
|
early cancer detection
|
|
gptkbp:foundedYear
|
1995
|
|
gptkbp:founder
|
gptkb:Stanley_Lapidus
|
|
gptkbp:headquartersLocation
|
gptkb:Madison,_Wisconsin,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Exact Sciences
|
|
gptkbp:industry
|
gptkb:biotechnology
molecular diagnostics
|
|
gptkbp:listedOn
|
gptkb:S&P_500
|
|
gptkbp:notableInvention
|
noninvasive colorectal cancer screening
|
|
gptkbp:notableProduct
|
gptkb:Cologuard
gptkb:Oncotype_DX
|
|
gptkbp:numberOfEmployees
|
approximately 6,500 (2023)
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:EXAS
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.exactsciences.com/
|
|
gptkbp:bfsParent
|
gptkb:EMET_Prize
|
|
gptkbp:bfsLayer
|
5
|